| abstract |
The invention provides methods for treating fibrosis, as well as methods for modulating mitochondrial peroxide production in a cell, and methods for modulating the import of Rac I into the mitochondria of a cell, comprising contacting the cell with an effective amount of a geranylgeranyl pyrophosphate (GGPP) synthase inhibitor or a pharmaceutically acceptable salt or prodrug thereof. |